SBC Medical Group Holdings Inc

SBC remains in a Stage 4 decline with persistent lower highs and lower lows and price trading below all major EMAs. The medium-term bias is bearish, as the active Post-Capitulation pattern signals only exhaustion without structural repair. Extreme oversold conditions counsel caution, so execution will focus on trimming into rallies toward the 9/20 EMA resistance zone.

• ↑Underlying revenue grew 111% YoY (ex-$8.7M fee impact) reflecting strong recovery
• ↑EBITDA +117% (ex-fee adjustments) underscoring improving margin trajectory
• ↓Total revenue -9% YoY to $43M after April fee structure changes